triiodothyronine has been researched along with Arteriosclerosis, Coronary in 28 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present work, research was carried out to explore the correlation between the high-density lipoprotein cholesterol (HDL-C)/apolipoprotein A-I (apoA-I) ratio and serum free triiodothyronine (FT3) and their interaction on the risk of coronary artery disease (CAD)." | 8.02 | The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk. ( Cai, G; Li, F; Li, L; Lu, W; Xiao, J; Yu, L, 2021) |
| "We assessed the prognostic implications of low triiodothyronine (T3) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in critically ill patients with acute heart failure." | 7.80 | Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure. ( Chuang, CP; Jong, YS; Lo, HM; Wu, CY, 2014) |
| "In the present work, research was carried out to explore the correlation between the high-density lipoprotein cholesterol (HDL-C)/apolipoprotein A-I (apoA-I) ratio and serum free triiodothyronine (FT3) and their interaction on the risk of coronary artery disease (CAD)." | 4.02 | The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk. ( Cai, G; Li, F; Li, L; Lu, W; Xiao, J; Yu, L, 2021) |
| "We assessed the prognostic implications of low triiodothyronine (T3) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in critically ill patients with acute heart failure." | 3.80 | Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure. ( Chuang, CP; Jong, YS; Lo, HM; Wu, CY, 2014) |
| "To survey the association of serum free triiodothyronine (FT3) level with coronary artery calcification and major adverse cardiac events (MACE) in outpatients with suspected coronary artery disease (CAD)." | 3.80 | [Relationship of serum free T3 with the coronary artery calcification and major adverse cardiac events in patients with suspected coronary artery disease]. ( Gao, C; Hao, P; Li, M; Liu, W; Qi, D; Wang, X; Zhang, Y; Zhu, L, 2014) |
| "To investigate the association between low free triiodothyronine (fT3) levels and the severity and prognosis of patients with acute myocardial infarction." | 3.78 | A low fT3 level as a prognostic marker in patients with acute myocardial infarctions. ( Li, W; Peng, W; Wang, C; Xu, Y; Zhang, B, 2012) |
| "These findings suggest that elevated cholesterol concentrations in the blood, especially against the background of suppressed thyroid function, can directly induce considerable damage to cardiomyocytes, intramural vessels, and erythrocytes without the development of myocardial ischemia and in the absence of atherosclerotic plaques." | 1.39 | Structural changes in the myocardium and serum lipid spectrum in experimental hypercholesterolemia and hypothyroidism. ( Klinnikova, MG; Lushnikova, EL; Molodykh, OP; Nepomnyashchikh, LM; Nepomnyashchikh, RD; Pichigin, VI; Polyakov, LP; Poteryaeva, ON; Russkikh, GS, 2013) |
| "Overt hypothyroidism has been found to be associated with cardiovascular disease." | 1.32 | Thyroid function is associated with presence and severity of coronary atherosclerosis. ( Auer, J; Berent, R; Eber, B; Lassnig, E; Weber, T, 2003) |
| "Triiodothyronine (T3) was significantly lower (P less than 0." | 1.27 | Progression and regression of human coronary atherosclerosis. The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth. ( Arntzenius, AC; Barth, JD; Birkenhager, JC; Jansen, H; Kromhout, D; Reiber, JH, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (21.43) | 29.6817 |
| 2010's | 16 (57.14) | 24.3611 |
| 2020's | 3 (10.71) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L | 1 |
| Cai, G | 1 |
| Lu, W | 1 |
| Li, F | 1 |
| Yu, L | 1 |
| Xiao, J | 1 |
| Zhang, H | 1 |
| Che, W | 1 |
| Shi, K | 1 |
| Huang, Y | 1 |
| Xu, C | 1 |
| Fei, M | 1 |
| Fan, X | 1 |
| Zhang, J | 2 |
| Hu, X | 1 |
| Hu, F | 1 |
| Qin, S | 1 |
| Zhang, X | 1 |
| Huang, Q | 1 |
| Yu, F | 1 |
| Yuan, D | 1 |
| Zhang, C | 1 |
| Jia, S | 1 |
| Liu, Y | 1 |
| Jiang, L | 1 |
| Xu, L | 1 |
| Zhang, Y | 4 |
| Xu, J | 1 |
| Xu, B | 2 |
| Hui, R | 1 |
| Gao, R | 1 |
| Gao, Z | 1 |
| Song, L | 1 |
| Yuan, J | 1 |
| Ortolani, PD | 1 |
| Romaldini, JH | 1 |
| Guerra, RA | 1 |
| Portes, ES | 1 |
| Meireles, GCX | 1 |
| Pimenta, J | 1 |
| Nepomnyashchikh, LM | 1 |
| Lushnikova, EL | 1 |
| Polyakov, LP | 1 |
| Molodykh, OP | 1 |
| Klinnikova, MG | 1 |
| Russkikh, GS | 1 |
| Poteryaeva, ON | 1 |
| Nepomnyashchikh, RD | 1 |
| Pichigin, VI | 1 |
| Chuang, CP | 1 |
| Jong, YS | 1 |
| Wu, CY | 1 |
| Lo, HM | 1 |
| Zhu, L | 2 |
| Gao, C | 2 |
| Wang, X | 2 |
| Qi, D | 2 |
| Li, M | 2 |
| Liu, W | 2 |
| Hao, P | 2 |
| Kim, BK | 1 |
| Chang, Y | 1 |
| Ryu, S | 1 |
| Cho, J | 1 |
| Lee, WY | 2 |
| Rhee, EJ | 2 |
| Kwon, MJ | 1 |
| Rampal, S | 1 |
| Zhao, D | 1 |
| Pastor-Barriuso, R | 1 |
| Lima, JA | 1 |
| Shin, H | 1 |
| Guallar, E | 1 |
| Park, HJ | 1 |
| Kim, J | 1 |
| Han, EJ | 1 |
| Park, SE | 1 |
| Park, CY | 1 |
| Oh, KW | 1 |
| Park, SW | 1 |
| Zhou, Y | 1 |
| Zhao, L | 1 |
| Wang, T | 1 |
| Hong, J | 1 |
| Huang, X | 1 |
| Xu, M | 1 |
| Bi, Y | 1 |
| Brozaitiene, J | 2 |
| Mickuviene, N | 1 |
| Podlipskyte, A | 2 |
| Burkauskas, J | 1 |
| Bunevicius, R | 3 |
| Coceani, M | 1 |
| Iervasi, G | 1 |
| Pingitore, A | 1 |
| Carpeggiani, C | 1 |
| L'Abbate, A | 1 |
| Tatar, E | 1 |
| Kircelli, F | 1 |
| Asci, G | 1 |
| Carrero, JJ | 1 |
| Gungor, O | 1 |
| Demirci, MS | 1 |
| Ozbek, SS | 1 |
| Ceylan, N | 1 |
| Ozkahya, M | 1 |
| Toz, H | 1 |
| Ok, E | 1 |
| Mishra, P | 1 |
| Samanta, L | 1 |
| Mugii, S | 1 |
| Hanada, H | 1 |
| Okubo, M | 1 |
| Masuda, D | 1 |
| Takeoka, K | 1 |
| Hidaka, Y | 1 |
| Ohama, T | 1 |
| Matsuyama, A | 1 |
| Nakagawa-Toyama, Y | 1 |
| Nishida, M | 1 |
| Ishigami, M | 1 |
| Komuro, I | 1 |
| Yamashita, S | 1 |
| Ertaş, F | 1 |
| Kaya, H | 1 |
| Soydinç, MS | 1 |
| Bunevicius, A | 1 |
| Gintauskiene, V | 2 |
| Zaliunas, R | 1 |
| Prange, AJ | 2 |
| Zhang, B | 1 |
| Peng, W | 1 |
| Wang, C | 1 |
| Li, W | 1 |
| Xu, Y | 1 |
| Mezősi, E | 1 |
| Bajnok, L | 1 |
| Tóth, K | 1 |
| Güden, M | 1 |
| Akpinar, B | 1 |
| Sagğbaş, E | 1 |
| Sanisoğlu, I | 1 |
| Cakali, E | 1 |
| Bayindir, O | 1 |
| Auer, J | 2 |
| Weber, T | 2 |
| Eber, B | 2 |
| CHURCH, G | 1 |
| LAWRIE, TD | 1 |
| PIRRIE, R | 1 |
| HERRMANN, GR | 1 |
| SAMAWI, A | 1 |
| Berent, R | 1 |
| Lassnig, E | 1 |
| Telkova, IL | 1 |
| Tepliakov, AT | 1 |
| Varoneckas, G | 1 |
| Hinderliter, AL | 1 |
| Girdler, SS | 1 |
| Barth, JD | 1 |
| Jansen, H | 1 |
| Kromhout, D | 1 |
| Reiber, JH | 1 |
| Birkenhager, JC | 1 |
| Arntzenius, AC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Endocrine Changes in Adults Undergoing Cardiac Surgery[NCT03736499] | 500 participants (Anticipated) | Observational | 2018-07-01 | Active, not recruiting | |||
| Effects of Dapagliflozin on Hyperlipidemia, Glycemic Control and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)[NCT02577159] | Phase 4 | 50 participants (Anticipated) | Interventional | 2015-07-01 | Active, not recruiting | ||
| Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction[NCT02512978] | Phase 4 | 160 participants (Anticipated) | Interventional | 2015-08-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for triiodothyronine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Oxidative stress and heart failure in altered thyroid States.
Topics: Animals; Atherosclerosis; Cardiomyopathies; Coronary Artery Disease; Heart Defects, Congenital; Hear | 2012 |
[The heart as an endocrine organ].
Topics: Adipocytes; Adipokines; Aldosterone; Biomarkers; Cardiomegaly; Coronary Artery Disease; Cytokines; H | 2012 |
1 trial available for triiodothyronine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Effects of intravenous triiodothyronine during coronary artery bypass surgery.
Topics: Aged; Arrhythmias, Cardiac; Cardiovascular System; Coronary Artery Bypass; Coronary Artery Disease; | 2002 |
25 other studies available for triiodothyronine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk.
Topics: Adult; Aged; Aged, 80 and over; Apolipoprotein A-I; Biomarkers; Cholesterol, HDL; Coronary Angiograp | 2021 |
FT4/FT3 ratio: A novel biomarker predicts coronary microvascular dysfunction (CMD) in euthyroid INOCA patients.
Topics: Biomarkers; Coronary Artery Disease; Humans; Myocardial Ischemia; Prospective Studies; Thyroxine; Tr | 2022 |
Predictive value of free triiodothyronine (FT3) to free thyroxine (FT4) ratio in long-term outcomes of euthyroid patients with three-vessel coronary artery disease.
Topics: Aged; Biomarkers; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis; Prospective | 2021 |
Association of serum thyrotropin levels with coronary artery disease documented by quantitative coronary angiography: a transversal study.
Topics: Age Factors; Aged; Cholesterol; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Cr | 2018 |
Structural changes in the myocardium and serum lipid spectrum in experimental hypercholesterolemia and hypothyroidism.
Topics: Animals; Atherosclerosis; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; | 2013 |
Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure.
Topics: Aged; Aged, 80 and over; Comorbidity; Coronary Artery Disease; Critical Illness; Diabetic Angiopathi | 2014 |
The effect of low FT3 levels on coronary artery calcification and MACE in outpatients with suspected coronary artery disease.
Topics: Aged; Biomarkers; Chi-Square Distribution; China; Coronary Angiography; Coronary Artery Bypass; Coro | 2014 |
Thyroid hormones and coronary artery calcification in euthyroid men and women.
Topics: Adult; Aged; Asymptomatic Diseases; Cohort Studies; Comorbidity; Coronary Artery Disease; Cross-Sect | 2014 |
[Relationship of serum free T3 with the coronary artery calcification and major adverse cardiac events in patients with suspected coronary artery disease].
Topics: Calcinosis; Coronary Artery Disease; Heart; Humans; Kaplan-Meier Estimate; Logistic Models; Risk Fac | 2014 |
Association of low baseline free thyroxin levels with progression of coronary artery calcification over 4 years in euthyroid subjects: the Kangbuk Samsung Health Study.
Topics: Adult; Aged; Coronary Artery Disease; Disease Progression; Euthyroid Sick Syndromes; Female; Humans; | 2016 |
Free Triiodothyronine Concentrations are Inversely Associated with Elevated Carotid Intima-Media Thickness in Middle-Aged and Elderly Chinese Population.
Topics: Adult; Aged; Biomarkers; Carotid Intima-Media Thickness; China; Coronary Artery Disease; Cross-Secti | 2016 |
Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; C-Reactive Protein; Coronary Artery Disease; Female; | 2016 |
Thyroid hormone and coronary artery disease: from clinical correlations to prognostic implications.
Topics: Aged; Biomarkers; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Euthyroid | 2009 |
Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients.
Topics: Carotid Artery Diseases; Carotid Intima-Media Thickness; Coronary Artery Disease; Female; Humans; Ma | 2011 |
Thyroid function influences serum apolipoprotein B-48 levels in patients with thyroid disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoprotein B-48; Atherosclerosis; Case-Control Studi | 2012 |
Low serum free triiodothyronine levels are associated with the presence and severity of coronary artery disease in the euthyroid patients: an observational study.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Coronary Angiography; Coronary Artery Disease; Female; H | 2012 |
Fatigue in patients with coronary artery disease: association with thyroid axis hormones and cortisol.
Topics: Adrenal Glands; Coronary Artery Disease; Cross-Sectional Studies; Exercise Test; Exercise Tolerance; | 2012 |
A low fT3 level as a prognostic marker in patients with acute myocardial infarctions.
Topics: Aged; Aged, 80 and over; Biomarkers; Coronary Artery Disease; Female; Humans; Kaplan-Meier Estimate; | 2012 |
Low triiodothyronine and cardiovascular disease.
Topics: Biomarkers; Comorbidity; Coronary Artery Disease; Cross-Sectional Studies; Follow-Up Studies; Humans | 2003 |
The effect of trilodothyroacetic acid on serum cholesterol and phospholipids in patients with coronary artery diseases.
Topics: Cholesterol; Coronary Artery Disease; Coronary Disease; Humans; Phospholipids; Triiodothyronine | 1957 |
The effects of various serum cholesterol lowering procedures and agents in patients with coronary artery disease.
Topics: Alcohols; Cholesterol; Coronary Artery Disease; Coronary Disease; Humans; Lipotropic Agents; Thyroxi | 1962 |
Thyroid function is associated with presence and severity of coronary atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studi | 2003 |
[Changes of thyroid hormone levels in the progression of coronary arteriosclerosis].
Topics: Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Disease Progression; Heart Fail | 2004 |
Depression and thyroid axis function in coronary artery disease: impact of cardiac impairment and gender.
Topics: Coronary Artery Disease; Depressive Disorder; Female; Humans; Hypothyroidism; Incidence; Lithuania; | 2006 |
Progression and regression of human coronary atherosclerosis. The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth.
Topics: Angiocardiography; Cholesterol, HDL; Coronary Artery Disease; Humans; Lipase; Lipoproteins; Male; Mi | 1987 |